Search
for
Sort by
Research 271–300 of 489
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Review of Promising Off-Label Use of Deucravacitinib
- CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Major Histocompatibility Complex Class I Chain-Related Gene A Polymorphisms and Extended Haplotypes Are Associated with Familial Alopecia Areata
- An Updated in the Management of Alopecia Areata
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Management of Alopecia Areata through Unani Medicine
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment
- Alopecia Areata in Twins With Autoimmune Thyroiditis: Personal Observations
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Baricitinib for the Treatment of Alopecia Areata
- A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata